Eye drop/contact lens solution manufacturer
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
350
NCT04149431
Multicenter Study to Evaluate Efficacy, Tolerability, Safety of Derinat
Phase: Phase 3
Role: Lead Sponsor
Start: Dec 15, 2019
Completion: May 31, 2022
Loading map...